Employees: 11-50
Portfolio 16
| Date | Name | Website | Total Raised | Location |
| 01.06.2023 | Sortina | sortinapharma.com | - | - |
| 01.06.2023 | SACRA | sacratherapeutics.com | - | - |
| 12.05.2023 | RAPP | rappab.com | - | Sweden |
| 08.11.2022 | Henlez | henlez.com | $1M | Denmark, C... |
| 10.07.2022 | ATTGENO | attgeno.com | - | - |
| 10.07.2022 | Hoba Thera... | hobatherapeutics.com | $24.76M | Denmark |
| 29.05.2022 | Cinclus Ph... | cincluspharma.com | $26.47M | Sweden, St... |
| 17.03.2022 | Strike Pha... | strikepharma.com | - | Sweden, Up... |
| 17.03.2022 | Scenic Bio... | scenicbiotech.com | $38.39M | Netherland... |
| 14.12.2021 | ArgusEye | arguseye.se | $3.03M | Sweden, Os... |
Show more
Persons 7
| Date | First Name | Last Name | Title | Location | |||
| - | Gökçe | Günaydın,... | - | - | g***e@eirv... | - | |
| - | Stephan | Christgau,... | - | - | s*****n@ei... | - | |
| - | Morten | Meldal, Ph... | - | - | - | - | |
| - | Amanda | Hayward, P... | - | - | a*********... | - | |
| - | Magnus | Persson, M... | - | - | m*********... | - | |
| - | Lovisa | Backemar,... | - | - | l****a@eir... | - | |
| - | Tobias | Horneman-T... | - | - | t****s@eir... | - |
News 36
| Date | Title | Description |
| 05.09.2024 | Eir Ventures Invests in Purpose Pharma | - |
| 11.12.2023 | Hoba Therapeutics raises EUR 23 million in a Series A to advance new drug candidate against chronic neuropathic pain | - |
| 18.10.2023 | Eir Ventures invests in Dania Tx | - |
| 10.07.2023 | Eir Ventures celebrates 3 years anniversary | - |
| 09.07.2023 | Lovisa Backemar new Principal. | - |
| 09.05.2023 | Eir invests in RAPP | - |
| 11.04.2023 | Eir invests in GutCRINE | - |
| 25.10.2022 | Eir Ventures invests in Henlez | - |
| 14.09.2022 | Eir Ventures portfolio company, Pretzel Therapeutics, announces USD 72,5M series A financing | - |
| 06.07.2022 | Eir Ventures invests in Hoba Therapeutics | - |
Show more
Mentions in press and media 11
| Date | Title | Description |
| 11.12.2023 | INDACO VENTURE PARTNERS – HOBA THERAPEUTICS RAISES EUR 23 MILLION IN A SERIES A TO ADVANCE NEW DRUG CANDIDATE AGAINST CHORNIC NEUROPATHIC PAIN | |
| 20.09.2022 | Pretzel Therapeutics Launches With $72.5M to Pioneer Mitochondrial Therapies | What You Should Know: Dysfunctional mitochondria are involved in more than 50 diseases. The most severe of these are broadly termed mitochondrial diseases, a group of rare genetic conditions which affect individuals of all ages. Mitochondri... |
| 10.03.2022 | Eir Ventures leads €28M investment in Scenic Biotec | - |
| 13.12.2021 | Eir Ventures Partners Closes Life Science Venture Fund, at EUR122M | Eir Ventures Partners AB, a Stockholm, Sweden- and Copenhagen, Denmark-based life science venture capital firm, closed its fund Eir Ventures I AB, at EUR 122.3m. Launched in 2020 with support from a strong investor syndicate comprising the ... |
| 09.12.2021 | Eir Ventures Closes Life Science Venture Fund at EUR122 million | - |
| 04.10.2021 | Finanțări pentru startup-uri medicale europene prin fonduri de investiții de 1,7 miliarde Euro | Startup-urile și firme mai dezvoltate, care inovează în medicină și alte științe ale vieții, au la dispoziție finanțări totale 1,7 miliarde de euro, prin 8 fonduri de investiții europene, susținute de UE și de mari companii, precum Google. ... |
| 13.01.2021 | Eir Ventures is delighted to announce our participation in the over subscribed €127M series B round in IO Biotech | - |
| 25.09.2020 | Eir Ventures co-leads high profile syndicate in €55 million investment in Galecto Biotech | - |
| 10.07.2020 | Eir Ventures Launches Fund to Back Health Care Innovation | Eir Ventures, a Stockholm, and Copenhagen, Denmark-based life science venture firm, held the first close of its new fund of EUR76m. The fund is launched with support from an investor syndicate comprising Saminvest, the European Investment F... |
| 10.07.2020 | New €76 million VC fund Eir Ventures aims to leverage the untapped potential of health care innovation in Europe | The Life Science venture fund Eir Ventures today announced a first closing of its new fund of €76 million. With a strong base in the Nordic region and a team of experienced life science investors, Eir Ventures will invest in innovative Euro... |
Show more